Changing paradigms in the follow-up of patients with differentiated thyroid cancer: an alternative to [18F]fluorodeoxyglucose positron emission tomographic scanning

Endocr Pract. 2003 Jul-Aug;9(4):324-6. doi: 10.4158/EP.9.4.324.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Humans
  • Neck / diagnostic imaging
  • Radiopharmaceuticals / pharmacokinetics
  • Thyroid Neoplasms / diagnostic imaging*
  • Thyrotropin / pharmacology
  • Tomography, Emission-Computed
  • Ultrasonography

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Thyrotropin